SCHEMBL18907186

SCHEMBL18907186

CCc1ccc2c(ccc3c4ccc5ccccc5c4nc(CC)c23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
CYP2A6 P11509 1/20 0.47
ATM Q13315 2/20 0.45
KIF11 P52732 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.39
MAPT P10636 1/20 0.39
MAOA P21397 2/20 0.37
AKR1B1 P15121 1/20 0.37
KMT2A Q03164 3/20 0.36
MAPK1 P28482 2/20 0.36
TYMS P04818 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 2/20 0.35
RAB9A P51151 3/20 0.35
ERBB2 P04626 1/20 0.35
FYN P06241 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907237 0.83 CYP1A2 (0.47) CYP1A2CYP2A6ATMKIF11L3MBTL1
SCHEMBL18907180 0.83 CYP1A2 (0.51) CYP1A2CYP2A6ATMKIF11L3MBTL1
SCHEMBL18907233 0.81 CYP1A2 (0.51) CYP1A2CYP2A6KIF11MAPTKMT2A
SCHEMBL598696 0.78 CYP1A2 (0.69) CYP1A2CYP2A6KIF11MAPTMAOA
SCHEMBL7773085 0.77 CYP1A2 (0.67) CYP1A2CYP2A6KIF11MAPTMAOA
SCHEMBL19009455 0.74 POLB (0.45) ATML3MBTL1KMT2AMAPK1KDM4E
SCHEMBL18907179 0.73 ATM (0.52) ATML3MBTL1MAPTMAOAKMT2A
SCHEMBL9765522 0.72 AKR1B1 (0.64) CYP1A2CYP2A6ATMKIF11L3MBTL1
SCHEMBL18907182 0.71 CYP1A2 (0.50) CYP1A2CYP2A6ATMKIF11L3MBTL1
SCHEMBL7794322 0.71 CYP1A2 (0.48) CYP1A2CYP2A6ATML3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 CYP1A2 421/4885CYP2A6 2320/4885ATM 3444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.